Market
why Nurix Therapeutics Inc [NRIX] is a Good Choice for Investors After New Price Target of $30.00
Nurix Therapeutics Inc [NASDAQ: NRIX] loss -3.87% or -0.51 points to close at $12.67 with a heavy trading volume of 4403661 shares. It opened the trading session at $14.48, the shares rose to $14.5604 and dropped to $12.09, the range by which the price of